Current Issues in Molecular Biology,
Journal Year:
2024,
Volume and Issue:
46(5), P. 4471 - 4488
Published: May 8, 2024
The
correlation
between
neurodegenerative
diseases
and
the
gut
microbiome
is
increasingly
evident,
with
amyotrophic
lateral
sclerosis
(ALS)
being
particularly
notable
for
its
severity
lack
of
therapeutic
options.
microbiota,
implicated
in
pathogenesis
development
ALS,
plays
a
crucial
role
disease.
Bioactive
plant
molecules,
specifically
volatile
compounds
essential
oils,
offer
promising
avenue
due
to
their
anti-inflammatory
properties
gut-modulating
effects.
Our
narrative
review
aimed
identify
microbiota-associated
bacteria
ALS
analyze
benefits
administering
bioactive
molecules
as
much-needed
options
management
this
A
comprehensive
search
PubMed
database
articles
published
before
December
2023,
encompassing
research
on
cell,
human,
animal
models,
was
conducted.
After
selecting,
analyzing,
discussing
key
articles,
linked
physiopathology
were
identified.
Notably,
positively
highlighted
included
Akkermansia
muciniphila
(Verrucomicrobia
phylum),
Faecalibacterium
prausnitzii,
Butyrivibrio
spp.
(Firmicutes
phylum).
Conversely,
members
Escherichia
coli
(Proteobacteria
phylum)
Ruminococcus
stood
out
negatively
respect
development.
These
associated
molecular
changes
evolution.
can
be
directly
improvements
microbiome,
reducing
inflammation
oxidative
stress,
emerging
one
most
natural
agents
enriching
present-day
treatments.
Current Chinese Science,
Journal Year:
2024,
Volume and Issue:
4(2), P. 145 - 157
Published: Feb. 4, 2024
Background:
Acorus
tatarinowii
and
Ginseng
(AT-G)
are
traditional
Chinese
herbal
medicines
extensively
utilized
in
neurological
disorders
treatment.
However,
due
to
the
complex
components
of
AT-G
pathological
mechanism
ASD,
mechanisms
involved
treatment
ASD
with
remain
elusive.
Objective:
We
explored
potential
Methods:
used
network
pharmacology
approach
evaluate
beneficial
effects
for
including
obtaining
active
by
Traditional
Medicine
Systems
Pharmacology
(TCMSP)
platform,
detecting
targets
genes
associated
Genecards
DisGenet
databases,
analysis,
virtual
docking.
Results:
A
total
26
components,
130
targets,
806
ASD-related
were
identified
using
bioinformatics
analysis
tool,
TCMSP,
Genecards,
DisGenet.
In
intersection
pharmacodynamic
we
41
common
targets.
Then,
GO
enrichment
revealed
that
mainly
biological
processes
(i.e.,
positive
regulation
nitric
oxide
biosynthetic
process,
response
xenobiotic
stimulus),
cellular
presynaptic
membrane
postsynaptic
membrane),
molecular
functions
RNA
polymerase
II
transcription
factor
activity,
identical
protein
binding).
KEGG
pathway
found
enriched
chemical
carcinogenesis
-
receptor
activation,
fluid
shear
stress
atherosclerosis,
lipid
IL-17
signaling
pathways.
addition,
10
core
screened
from
PPI
(e.g.,
TNF,
AKT1,
PTGS2,
MMP,
PPARG,
IFNG,
NOS2,
TGFB1,
CASP1).
Molecular
docking
component
kaempferol
has
a
high
affinity
four
primary
disease
Conclusion:
Our
results
facilitated
in-depth
development
their
individual
provided
reference
clinical
practice
Medicine,
Journal Year:
2024,
Volume and Issue:
103(15), P. e37740 - e37740
Published: April 12, 2024
Explore
Acori
Tatarinowii
Rhizoma
(ATR)
and
Polygalae
Radix
(PR)
mechanisms
in
Alzheimer’s
disease
(AD)
treatment
through
network
pharmacology.
ATR-PR
was
investigated
the
Traditional
Chinese
Medicine
Systems
Pharmacology
(TCMSP)
database,
Batman,
Medicines
Integrated
Database
(TCMID)
to
gather
information
on
its
chemical
components
target
proteins.
Target
genes
associated
with
AD
were
retrieved
from
GeneCards
National
Center
for
Biotechnology
Information
(NCBI)
databases.
The
integration
of
these
datasets
potential
targets
facilitated
construction
an
protein-protein
interaction
(PPI)
using
STRING
database.
resulting
identified
core
active
ingredients
main
treatment.
Cluster
analysis
PPI
performed
Cytoscape
3.7.1.
Gene
Ontology
(GO)
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
enrichment
analyses
conducted
Metascape
Molecular
docking
simulations
revealed
interactions
between
targets.
Our
8
putative
455
ATR-PR.
We
systematically
searched
1306
AD,
Venn
diagram
156
common
targets,
constructed
a
57
key
GO
functional
highlighted
primary
biological
processes
oxidative
stress.
KEGG
pathway
involvement
64
signaling
pathways,
PI3K/Akt
playing
role.
indicated
high
affinity
compounds
AD.
This
study
sheds
light
complex
involving
context
provide
foundation
understanding
therapeutic
mechanisms.
stress-related
crucial
role
suggest
avenues
targeted
interventions
proposition
combined
use
has
emerged
as
strategy
supported
by
pharmacology
approach.
framework
provides
robust
future
clinical
applications
experimental
research
pursuit
effective
treatments.
Current Issues in Molecular Biology,
Journal Year:
2024,
Volume and Issue:
46(5), P. 4471 - 4488
Published: May 8, 2024
The
correlation
between
neurodegenerative
diseases
and
the
gut
microbiome
is
increasingly
evident,
with
amyotrophic
lateral
sclerosis
(ALS)
being
particularly
notable
for
its
severity
lack
of
therapeutic
options.
microbiota,
implicated
in
pathogenesis
development
ALS,
plays
a
crucial
role
disease.
Bioactive
plant
molecules,
specifically
volatile
compounds
essential
oils,
offer
promising
avenue
due
to
their
anti-inflammatory
properties
gut-modulating
effects.
Our
narrative
review
aimed
identify
microbiota-associated
bacteria
ALS
analyze
benefits
administering
bioactive
molecules
as
much-needed
options
management
this
A
comprehensive
search
PubMed
database
articles
published
before
December
2023,
encompassing
research
on
cell,
human,
animal
models,
was
conducted.
After
selecting,
analyzing,
discussing
key
articles,
linked
physiopathology
were
identified.
Notably,
positively
highlighted
included
Akkermansia
muciniphila
(Verrucomicrobia
phylum),
Faecalibacterium
prausnitzii,
Butyrivibrio
spp.
(Firmicutes
phylum).
Conversely,
members
Escherichia
coli
(Proteobacteria
phylum)
Ruminococcus
stood
out
negatively
respect
development.
These
associated
molecular
changes
evolution.
can
be
directly
improvements
microbiome,
reducing
inflammation
oxidative
stress,
emerging
one
most
natural
agents
enriching
present-day
treatments.